메뉴 건너뛰기




Volumn 28, Issue 32, 2010, Pages 5338-5346

Three novel NY-ESO-1 epitopes bound to DRB10803, DQB10401 and DRB1 0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patients

Author keywords

CD4 epitopes; NY ESO 1; Tumor immunology

Indexed keywords

CD4 ANTIGEN; CHOLESTEROL BEARING HYDROPHOBIZED PULLULAN NY ESO 1 PROTEIN; HLA DR ANTIGEN; LEUCYLLEUCYLGLUTAMYLPHENYLALANYLTYROSYLLEUCYLALANYLMETHIONYLPROLYLPHENYLALANYLALANYLTHREONYLPROLYLMETHIONINE; LYSYLGLUTAMYLPHENYLALANYLTHREONYLVALYLSERYLGLYCYLASPARAGINYLISOLEUCYLLEUCYLTHREONINE; NY ESO 1 ANTIGEN; PROLYLPHENYLALANYLALANYLTHREONYLPROLYLMETHIONYLGLUTAMYLALANYLGLUTAMYLLEUCYLALANYLARGINYLARGININE; RECOMBINANT PROTEIN; TETRAMER; UNCLASSIFIED DRUG; CANCER VACCINE; EPITOPE; HLA DRB1 ANTIGEN; TUMOR PROTEIN;

EID: 77955013191     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.05.044     Document Type: Article
Times cited : (7)

References (33)
  • 1
    • 12644276375 scopus 로고    scopus 로고
    • A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
    • Chen Y.T., Scanlan M.J., Sahin U., Türeci O., Gure A.O., Tsang S., et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997, 94:1914-1918.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 1914-1918
    • Chen, Y.T.1    Scanlan, M.J.2    Sahin, U.3    Türeci, O.4    Gure, A.O.5    Tsang, S.6
  • 4
    • 0035876940 scopus 로고    scopus 로고
    • Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
    • Jungbluth A.A., Chen Y.T., Stockert E., Busam K.J., Kolb D., Iversen K., et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001, 92:856-860.
    • (2001) Int J Cancer , vol.92 , pp. 856-860
    • Jungbluth, A.A.1    Chen, Y.T.2    Stockert, E.3    Busam, K.J.4    Kolb, D.5    Iversen, K.6
  • 5
    • 2642673605 scopus 로고    scopus 로고
    • A survey of the humoral immune response of cancer patients to a panel of human tumor antigens
    • Stockert E., Jäger E., Chen Y.T., Scanlan M.J., Gout I., Karbach J., et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 1998, 187:1349-1354.
    • (1998) J Exp Med , vol.187 , pp. 1349-1354
    • Stockert, E.1    Jäger, E.2    Chen, Y.T.3    Scanlan, M.J.4    Gout, I.5    Karbach, J.6
  • 6
    • 0033595632 scopus 로고    scopus 로고
    • Humoral immune responses of cancer patients against " Cancer-Testis" antigen NY-ESO-1: correlation with clinical events
    • Jäger E., Stockert E., Zidianakis Z., Chen Y.T., Karbach J., Jäger D., et al. Humoral immune responses of cancer patients against " Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. Int J Cancer 1999, 84:506-510.
    • (1999) Int J Cancer , vol.84 , pp. 506-510
    • Jäger, E.1    Stockert, E.2    Zidianakis, Z.3    Chen, Y.T.4    Karbach, J.5    Jäger, D.6
  • 7
    • 0041305899 scopus 로고    scopus 로고
    • Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses
    • Gnjatic S., Atanackovic D., Jäger E., Matsuo M., Selvakumar A., Altorki N.K., et al. Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. Proc Natl Acad Sci USA 2003, 100:8862-8867.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 8862-8867
    • Gnjatic, S.1    Atanackovic, D.2    Jäger, E.3    Matsuo, M.4    Selvakumar, A.5    Altorki, N.K.6
  • 8
    • 0038691976 scopus 로고    scopus 로고
    • Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses
    • Jäger E., Nagata Y., Gnjatic S., Wada H., Stockert E., Karbach J., et al. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci USA 2000, 97:4760-4765.
    • (2000) Proc Natl Acad Sci USA , vol.97 , pp. 4760-4765
    • Jäger, E.1    Nagata, Y.2    Gnjatic, S.3    Wada, H.4    Stockert, E.5    Karbach, J.6
  • 9
    • 33646083008 scopus 로고    scopus 로고
    • Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1
    • Nicholaou T., Ebert L., Davis I.D., Robson N., Klein O., Maraskovsky E., et al. Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1. Immunol Cell Biol 2006, 84:303-307.
    • (2006) Immunol Cell Biol , vol.84 , pp. 303-307
    • Nicholaou, T.1    Ebert, L.2    Davis, I.D.3    Robson, N.4    Klein, O.5    Maraskovsky, E.6
  • 10
    • 3242658810 scopus 로고    scopus 로고
    • Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans
    • Davis I.D., Chen W., Jackson H., Parente P., Shackleton M., Hopkins W., et al. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proc Natl Acad Sci USA 2004, 101:10697-10702.
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 10697-10702
    • Davis, I.D.1    Chen, W.2    Jackson, H.3    Parente, P.4    Shackleton, M.5    Hopkins, W.6
  • 11
    • 34247485458 scopus 로고    scopus 로고
    • T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein
    • Uenaka A., Wada H., Isobe M., Saika T., Tsuji K., Sato E., et al. T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. Cancer Immun 2007, 7:9.
    • (2007) Cancer Immun , vol.7 , pp. 9
    • Uenaka, A.1    Wada, H.2    Isobe, M.3    Saika, T.4    Tsuji, K.5    Sato, E.6
  • 12
    • 34547475142 scopus 로고    scopus 로고
    • Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
    • Valmori D., Souleimanian N.E., Tosello V., Bhardwaj N., Adams S., O'Neill D., et al. Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming. Proc Natl Acad Sci USA 2007, 104:8947-8952.
    • (2007) Proc Natl Acad Sci USA , vol.104 , pp. 8947-8952
    • Valmori, D.1    Souleimanian, N.E.2    Tosello, V.3    Bhardwaj, N.4    Adams, S.5    O'Neill, D.6
  • 13
    • 47949129948 scopus 로고    scopus 로고
    • Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant
    • Adams S., O'Neill D.W., Nonaka D., Hardin E., Chiriboga L., Siu K., et al. Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant. J Immunol 2008, 181:776-784.
    • (2008) J Immunol , vol.181 , pp. 776-784
    • Adams, S.1    O'Neill, D.W.2    Nonaka, D.3    Hardin, E.4    Chiriboga, L.5    Siu, K.6
  • 14
    • 33749237126 scopus 로고    scopus 로고
    • Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients
    • Jäger E., Karbach J., Gnjatic S., Neumann A., Bender A., Valmori D., et al. Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients. Proc Natl Acad Sci USA 2006, 103:14453-14458.
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 14453-14458
    • Jäger, E.1    Karbach, J.2    Gnjatic, S.3    Neumann, A.4    Bender, A.5    Valmori, D.6
  • 15
    • 34147101570 scopus 로고    scopus 로고
    • Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients
    • Kawabata R., Wada H., Isobe M., Saika T., Sato S., Uenaka A., et al. Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients. Int J Cancer 2007, 120:2178-2184.
    • (2007) Int J Cancer , vol.120 , pp. 2178-2184
    • Kawabata, R.1    Wada, H.2    Isobe, M.3    Saika, T.4    Sato, S.5    Uenaka, A.6
  • 16
    • 48149088825 scopus 로고    scopus 로고
    • Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient
    • Tsuji K., Hamada T., Uenaka A., Wada H., Sato E., Isobe M., et al. Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient. Cancer Immunol Immunother 2008, 57:1429-1437.
    • (2008) Cancer Immunol Immunother , vol.57 , pp. 1429-1437
    • Tsuji, K.1    Hamada, T.2    Uenaka, A.3    Wada, H.4    Sato, E.5    Isobe, M.6
  • 17
    • 53449084664 scopus 로고    scopus 로고
    • Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination
    • Wada H., Sato E., Uenaka A., Isobe M., Kawabata R., Nakamura Y., et al. Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination. Int J Cancer 2008, 123:2362-2369.
    • (2008) Int J Cancer , vol.123 , pp. 2362-2369
    • Wada, H.1    Sato, E.2    Uenaka, A.3    Isobe, M.4    Kawabata, R.5    Nakamura, Y.6
  • 18
    • 20244384857 scopus 로고    scopus 로고
    • Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions
    • Murphy R., Green S., Ritter G., Cohen L., Ryan D., Woods W., et al. Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions. Prep Biochem Biotechnol 2005, 35:119-134.
    • (2005) Prep Biochem Biotechnol , vol.35 , pp. 119-134
    • Murphy, R.1    Green, S.2    Ritter, G.3    Cohen, L.4    Ryan, D.5    Woods, W.6
  • 19
    • 0028877293 scopus 로고
    • Rejection antigen peptides on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes: derivation from the normally untranslated 5'-region of the c-akt proto-oncogene activated by LTR
    • Wada H., Matsuo M., Uenaka A., Shimbara N., Shimizu K., Nakayama E. Rejection antigen peptides on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes: derivation from the normally untranslated 5'-region of the c-akt proto-oncogene activated by LTR. Cancer Res 1995, 55:4780-4783.
    • (1995) Cancer Res , vol.55 , pp. 4780-4783
    • Wada, H.1    Matsuo, M.2    Uenaka, A.3    Shimbara, N.4    Shimizu, K.5    Nakayama, E.6
  • 20
    • 0035875056 scopus 로고    scopus 로고
    • NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade
    • Kurashige T., Noguchi Y., Saika T., Ono T., Nagata Y., Jungbluth A., et al. NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Cancer Res 2001, 61:4671-4674.
    • (2001) Cancer Res , vol.61 , pp. 4671-4674
    • Kurashige, T.1    Noguchi, Y.2    Saika, T.3    Ono, T.4    Nagata, Y.5    Jungbluth, A.6
  • 21
    • 55949114186 scopus 로고    scopus 로고
    • Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions
    • Cecconi V., Moro M., Del Mare S., Dellabona P., Casorati G. Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions. Cytometry A 2008, 73:1010-1018.
    • (2008) Cytometry A , vol.73 , pp. 1010-1018
    • Cecconi, V.1    Moro, M.2    Del Mare, S.3    Dellabona, P.4    Casorati, G.5
  • 22
    • 0034662263 scopus 로고    scopus 로고
    • Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules
    • Zeng G., Touloukian C.E., Wang X., Restifo N.P., Rosenberg S.A., Wang R.F. Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules. J Immunol 2000, 165:1153-1159.
    • (2000) J Immunol , vol.165 , pp. 1153-1159
    • Zeng, G.1    Touloukian, C.E.2    Wang, X.3    Restifo, N.P.4    Rosenberg, S.A.5    Wang, R.F.6
  • 23
    • 0034282998 scopus 로고    scopus 로고
    • NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells
    • Zarour H.M., Storkus W.J., Brusic V., Williams E., Kirkwood J.M. NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells. Cancer Res 2000, 60:4946-4952.
    • (2000) Cancer Res , vol.60 , pp. 4946-4952
    • Zarour, H.M.1    Storkus, W.J.2    Brusic, V.3    Williams, E.4    Kirkwood, J.M.5
  • 24
    • 34249893960 scopus 로고    scopus 로고
    • Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population
    • Ohkuri T., Sato M., Abe H., Tsuji K., Yamagishi Y., Ikeda H., et al. Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population. Cancer Sci 2007, 98:1092-1098.
    • (2007) Cancer Sci , vol.98 , pp. 1092-1098
    • Ohkuri, T.1    Sato, M.2    Abe, H.3    Tsuji, K.4    Yamagishi, Y.5    Ikeda, H.6
  • 25
    • 0034695886 scopus 로고    scopus 로고
    • Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma
    • Jäger E., Jäger D., Karbach J., Chen Y.T., Ritter G., Nagata Y., et al. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. J Exp Med 2000, 191:625-630.
    • (2000) J Exp Med , vol.191 , pp. 625-630
    • Jäger, E.1    Jäger, D.2    Karbach, J.3    Chen, Y.T.4    Ritter, G.5    Nagata, Y.6
  • 26
    • 12944265542 scopus 로고    scopus 로고
    • Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele
    • Gnjatic S., Nagata Y., Jager E., Stockert E., Shankara S., Roberts B.L., et al. Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc Natl Acad Sci USA 2000, 97:10917-10922.
    • (2000) Proc Natl Acad Sci USA , vol.97 , pp. 10917-10922
    • Gnjatic, S.1    Nagata, Y.2    Jager, E.3    Stockert, E.4    Shankara, S.5    Roberts, B.L.6
  • 27
    • 85044704273 scopus 로고    scopus 로고
    • Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51
    • Jäger E., Karbach J., Gnjatic S., Jäger D., Maeurer M., Atmaca A., et al. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51. Cancer Immun 2002, 2:12.
    • (2002) Cancer Immun , vol.2 , pp. 12
    • Jäger, E.1    Karbach, J.2    Gnjatic, S.3    Jäger, D.4    Maeurer, M.5    Atmaca, A.6
  • 28
    • 0345016358 scopus 로고    scopus 로고
    • Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes
    • Benlalam H., Linard B., Guilloux Y., Moreau-Aubry A., Derré L., Diez E., et al. Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes. J Immunol 2003, 171:6283-6289.
    • (2003) J Immunol , vol.171 , pp. 6283-6289
    • Benlalam, H.1    Linard, B.2    Guilloux, Y.3    Moreau-Aubry, A.4    Derré, L.5    Diez, E.6
  • 29
    • 19944430099 scopus 로고    scopus 로고
    • One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma
    • Mandic M., Castelli F., Janjic B., Almunia C., Andrade P., Gillet D., et al. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma. J Immunol 2005, 174:1751-1759.
    • (2005) J Immunol , vol.174 , pp. 1751-1759
    • Mandic, M.1    Castelli, F.2    Janjic, B.3    Almunia, C.4    Andrade, P.5    Gillet, D.6
  • 30
    • 67650375847 scopus 로고    scopus 로고
    • Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire
    • Bioley G., Dousset C., Yeh A., Dupont B., Bhardwaj N., Mears G., et al. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire. Clin Cancer Res 2009, 15:4467-4474.
    • (2009) Clin Cancer Res , vol.15 , pp. 4467-4474
    • Bioley, G.1    Dousset, C.2    Yeh, A.3    Dupont, B.4    Bhardwaj, N.5    Mears, G.6
  • 31
    • 0036141435 scopus 로고    scopus 로고
    • NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells
    • Zarour H.M., Maillere B., Brusic V., Coval K., Williams E., Pouvelle-Moratille S., et al. NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells. Cancer Res 2002, 62:213-218.
    • (2002) Cancer Res , vol.62 , pp. 213-218
    • Zarour, H.M.1    Maillere, B.2    Brusic, V.3    Coval, K.4    Williams, E.5    Pouvelle-Moratille, S.6
  • 32
    • 44249118831 scopus 로고    scopus 로고
    • Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1
    • Matsuzaki J., Qian F., Luescher I., Lele S., Ritter G., Shrikant P.A., et al. Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1. Cancer Immunol Immunother 2008, 57:1185-1195.
    • (2008) Cancer Immunol Immunother , vol.57 , pp. 1185-1195
    • Matsuzaki, J.1    Qian, F.2    Luescher, I.3    Lele, S.4    Ritter, G.5    Shrikant, P.A.6
  • 33
    • 63549100184 scopus 로고    scopus 로고
    • Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma
    • Nicholaou T., Ebert L.M., Davis I.D., McArthur G.A., Jackson H., Dimopoulos N., et al. Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma. Clin Cancer Res 2009, 15:2166-2173.
    • (2009) Clin Cancer Res , vol.15 , pp. 2166-2173
    • Nicholaou, T.1    Ebert, L.M.2    Davis, I.D.3    McArthur, G.A.4    Jackson, H.5    Dimopoulos, N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.